Express Scripts sues Federal Trade Commission for defamation, demands retraction
Headquartered in North St. Louis County, Express Scripts, a subsidiary of The Cigna Group, is demanding the FTC retract a report it made in July 2024 that said the pharmacy benefit management industry drives up drug prices consumers pay.
21 (UPI) --A federal judge in Texas blocked the Federal Trade Commission's ban on non-compete ... eliminate such contract language, ruling the FTC lacked the authority to issue the ban.
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...
The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...
UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.
At this week’s National Advertising Division Annual Conference, FTC Commissioner Melissa Holyoak and FTC Bureau of Consumer Protection Director ...
A decision on the Federal Trade Commission’s noncompete ban came down to the wire. A federal judge in Texas recently blocked the FTC’s noncompete ban, which was approved by the commission ...
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback